It is noteworthy that the inhibition of SPT4 in human cells and model organisms has been proposed as a strategy to reduce aberrant transcription across repeat expansions in certain neurological diseases, including the case of R-loop-prone C9orf72 gene expanded in ALS [68, 69]. The gene discussed is SUPT4H1; the disease is amyotrophic lateral sclerosis.